Cross-linking of ΔF508-CFTR promotes its trafficking to the plasma membrane

被引:1
作者
Bernard, Karen
Kirk, Kevin L. [1 ]
机构
[1] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA
关键词
cystic fibrosis; endoplasmic reticulum; oligomer; processing mutation; curcumin; TRANSMEMBRANE CONDUCTANCE REGULATOR; CURCUMIN; CFTR;
D O I
10.4161/chan.4.4.12198
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CFTR is a cAMP-activated chloride channel responsible for agonist stimulated chloride and fluid transport across epithelial surfaces.(1) Mutations in the CFTR gene lead to cystic fibrosis (CF) which affects the function of secretory organs like the intestine, the pancreas, the airways and the sweat glands. Most of the morbidity and mortality in CF has been linked to a decrease in airway function.(2) The Delta F508 mutation is the most common CF-related mutation in the Caucasian population and represents 90% of CF alleles. Homozygote carriers of this mutation present with a severe CF phenotype.(3) The Delta F508 mutation causes misfolding of the nascent CFTR polypeptide, which leads to inefficient export from the endoplasmic reticulum (ER) and rapid degradation by the proteasome.(4)
引用
收藏
页码:251 / 254
页数:4
相关论文
共 13 条
  • [1] Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature
    Anand, Preetha
    Thomas, Sherin G.
    Kunnumakkara, Ajaikumar B.
    Sundaram, Chitra
    Harikumar, Kuzhuvelil B.
    Sung, Bokyung
    Tharakan, Sheeja T.
    Misra, Krishna
    Priyadarsini, Indira K.
    Rajasekharan, Kallikat N.
    Aggarwal, Bharat B.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2008, 76 (11) : 1590 - 1611
  • [2] Curcumin stimulates cystic fibrosis transmembrane conductance regulator Cl- channel activity
    Berger, AL
    Randak, CO
    Ostedgaard, LS
    Karp, PH
    Vermeer, DW
    Welsh, MJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (07) : 5221 - 5226
  • [3] Curcumin Cross-links Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Polypeptides and Potentiates CFTR Channel Activity by Distinct Mechanisms
    Bernard, Karen
    Wang, Wei
    Narlawar, Rajeshwar
    Schmidt, Boris
    Kirk, Kevin L.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (45) : 30754 - 30765
  • [4] Rescuing cystic fibrosis transmembrane conductance regulator (CFTR) processing mutants by transcomplementation
    Cormet-Boyaka, E
    Jablonsky, M
    Naren, AP
    Jackson, PL
    Muccio, DD
    Kirk, KL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (21) : 8221 - 8226
  • [5] Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects
    Egan, ME
    Pearson, M
    Weiner, SA
    Rajendran, V
    Rubin, D
    Glöckner-Pagel, J
    Canny, S
    Du, K
    Lukacs, GL
    Caplan, MJ
    [J]. SCIENCE, 2004, 304 (5670) : 600 - 602
  • [6] FRIZZELL RA, 1995, AM J RESP CRIT CARE, V151, P54
  • [7] Molecular assembly of cystic fibrosis transmembrane conductance regulator in plasma membrane
    Li, CY
    Roy, K
    Dandridge, K
    Naren, AP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (23) : 24673 - 24684
  • [8] Clinical implications of cystic fibrosis transmembrane conductance regulator mutations
    Mickle, JE
    Cutting, GR
    [J]. CLINICS IN CHEST MEDICINE, 1998, 19 (03) : 443 - +
  • [9] Design and synthesis of a hybrid potentiator-corrector agonist of the cystic fibrosis mutant protein ΔF508-CFTR
    Mills, Aaron D.
    Yoo, Choong
    Butler, Jeffrey D.
    Yang, Baoxue
    Verkman, A. S.
    Kurth, Mark J.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) : 87 - 91
  • [10] Pilewski JM, 1999, PHYSIOL REV, V79, P215